近期论文

查看导师最新文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

BURR SA, WHITTLE J, FAIRCLOUGH LC, COOMBES L and TODD I, 2016. Modifying Hofstee standard setting for assessments that vary in difficulty, and to determine boundaries for different levels of achievement. BMC medical education. 16, 34 SELVARAJAH S, TODD I, TIGHE PJ, JOHN M, BOLTON CE, HARRISON T and FAIRCLOUGH LC, 2016. Multiple Circulating Cytokines Are Coelevated in Chronic Obstructive Pulmonary Disease. Mediators of inflammation. 2016, 3604842 TUBBY C, NEGM OH, HARRISON T, TIGHE PJ, TODD I and FAIRCLOUGH LC, 2016. Peripheral killer cells do not differentiate between asthma patients with or without fixed airway obstruction. The Journal of asthma : official journal of the Association for the Care of Asthma. 0 MOZ S, BASSO D, BOZZATO D, GALOZZI P, NAVAGLIA F, NEGM OH, ARRIGONI G, ZAMBON CF, PADOAN A, TIGHE P, TODD I, FRANCHIN C, PEDRAZZOLI S, PUNZI L and PLEBANI M, 2016. SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells. Oncotarget. (In Press.) AYLING K, BOWDEN T, TIGHE P, TODD I, DILNOT EM, NEGM OH, FAIRCLOUGH L and VEDHARA K, 2016. The application of protein microarray assays in psychoneuroimmunology. Brain, behavior, and immunity. FAIRCLOUGH LC, STOOP AA, NEGM OH, RADFORD PM, TIGHE PJ and TODD I, 2015. Tumour necrosis factor receptor I blockade shows that TNF-dependent and TNF-independent mechanisms synergise in TNF receptor associated periodic syndrome. European journal of immunology. 45(10), 2937-44 TIGHE PJ, RYDER RR, TODD I and FAIRCLOUGH LC, 2015. ELISA in the multiplex era: potentials and pitfalls. Proteomics. Clinical applications. 9(3-4), 406-22 DAFFA NI, TIGHE PJ, CORNE JM, FAIRCLOUGH LC and TODD I, 2015. Natural and disease-specific autoantibodies in chronic obstructive pulmonary disease. Clinical and experimental immunology. 180(1), 155-63 SELVARAJAH S, NEGM OH, HAMED MR, TUBBY C, TODD I, TIGHE PJ, HARRISON T and FAIRCLOUGH LC, 2014. Development and validation of protein microarray technology for simultaneous inflammatory mediator detection in human sera. Mediators of inflammation. 2014, 820304 NEGM, OLA H., MANNSPERGER, HEIKO A., MCDERMOTT, ELIZABETH M., DREWE, ELIZABETH, POWELL, RICHARD J., TODD, IAN, FAIRCLOUGH, LUCY C. and TIGHE, PATRICK J., 2014. A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS) EUROPEAN JOURNAL OF IMMUNOLOGY. 44(7), 2096-2110 ALOTIBY, A. A., FAIRCLOUGH, L. C., TODD, I. and TIGHE, P. J., 2014. Generation and characterisation of transcription activator-like effector nucleases (TALENs) targeting TNFR1 genome editing IMMUNOLOGY. 143, 95-95 HALALA, R. A., TIGHE, P., TODD, I. and FAIRCLOUGH, L., 2014. Profiling of natural autoantibodies in relation to chronic obstructive pulmonary disease IMMUNOLOGY. 143, 79-79 TARBIAH, N., TIGHE, P., FAIRCLOUGH, L. and TODD, I., 2014. Comparing between smokers and non-smokers immunoglobulin levels and B-cell differentiation IMMUNOLOGY. 143, 81-81 ALBOGAMI, S., NEGM, O., ZANG, L., THOMAS, N., FAIRCLOUGH, L., TODD, I. and TIGHE, P., 2014. The inhibitory effects of recombinant PLAD wild type (WT) protein on the inflammatory signalling pathways IMMUNOLOGY. 143, 125-125 HAMED, A., TODD, I., TIGHE, P., POWELL, R. and FAIRCLOUGH, L., 2014. Development of IgE microarray assays for classification of allergic individuals IMMUNOLOGY. 143, 170-170 TODD I, BURR S, WHITTLE J and FAIRCLOUGH L, 2014. Modifying the Hofstee method may overcome problems. Medical teacher. 36(4), 358-9 GALOZZI, P., GRECO, E., GAVA, A., BASSO, D., SFRISO, P., TIGHE, P., TODD, I. and PUNZI, L., 2014. FUNCTIONAL CHARACTERIZATION OF P.E383K BLAU SYNDROME-RELATED MUTATION ANNALS OF THE RHEUMATIC DISEASES. 73, 807-807 VAITLA, P.M., RADFORD, P.M., TIGHE, P.J., POWELL, R.J., MCDERMOTT, E.M., TODD, I. and DREWE, E., 2011. Role of interleukin-6 in a patient with tumor necrosis factor receptor–associated periodic syndrome: Assessment of outcomes following treatment with the anti–interleukin-6 receptor monoclonal antibody tocilizumab Arthritis and Rheumatism. 63(4), 1151-1155 REBELO, S. L, P. M. RADFORD, S. E. BAINBRIDGE, I. TODD and P. J. TIGHE, 2011. Functional Consequences of Disease-Associated Mutations in TNFR1 Elucidated by Transcriptome Analysis Adv Exp Med Biol. 461-70 TUBBY, C., HARRISON, T., TODD, I. and FAIRCLOUGH, L., 2011. Immunological basis of reversible and fixed airways disease Clinical Science. 121(7), 285-296 URBANOWICZ, R.A., LAMB, J.R., TODD, I., CORNE, J.M. and FAIRCLOUGH, L.C., 2010. Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients Respiratory Research. 11, 76 URBANOWICZ, R.A, LAMB, J.R., TODD, I., CORNE, J.M. and FAIRCLOUGH, L.C., 2009. Altered effector function of peripheral cytotoxic cells in COPD Respiratory Research. 10(June), 53 REBELO, S.L., AMEL-KASHIPAZ, M.R., RADFORD,, P.M., BAINBRIDGE, S.E., FIETS, R., FANG, J., MCDERMOTT, E.M., POWELL, R.J., TODD, I. and TIGHE, P.J., 2009. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line Arthritis and Rheumatism. 60(1), 269-280 TODD, I., RADFORD, P.M., DAFFA, N., BAINBRIDGE, S.E., POWELL, R.J. and TIGHE, P.J., 2007. Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes Arthritis and Rheumatism. 56(8), 2765-2773 TODD, I., RADFORD, P.M., ZIEGLER-HEITBROCK, L., GHAEMMAGHAMI, A., POWELL R.J and TIGHE, P.J., 2007. Elevated CD16 expression by monocytes from patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis and Rheumatism. 56(12), 4182-4188